Deuterium Metabolic Imaging to measure hepatic fructose metabolism


Published June 30, 2025

Chronic intake of high amounts of fructose has been linked to the development of metabolic disorders caused by the almost complete clearance of fructose by the liver. However, direct measurement of hepatic fructose uptake is complicated by the fact that the portal vein is difficult to access. 

Dr. Arjan Hendriks, from the University Medical Center Utrecht, applied for access at the PRIME Node to explore the opportunities and potential effectiveness of different deuterated compounds to map body metabolism with deuterium metabolic imaging (DMI), and thanks to the data obtained during this access he developed a new, non-invasive method to measure hepatic fructose uptake and metabolism, based on administration of [6,6’-2H2]fructose followed by DMI. 

issue concentration of deuterated glucose and/or fructose
Tissue concentration of deuterated glucose and/or fructose, and of deuterated water as a function of time during and after a bolus injection versus a slow IV infusion of [6,6’-2H2]glucose and [6,6’-2H2]fructose. Figures have been adapted from: https://doi.org/10.3389/fphys.2023.1198578 Used under a Creative Commons CC-BY 4.0 license.

The application of this method in mice showed a higher extraction and faster turnover of fructose in the liver, as compared with glucose. Furthermore, comparing high concentration bolus injections with a slow low concentration infusion gave more insight into the fructose build up in the liver as compared to glucose. DMI with [6,6’-2H2]glucose and [6,6’-2H2]fructose could potentially contribute to a better understanding of healthy human liver metabolism and aberrations in metabolic diseases.

In vivo anatomical 3D MR images
In vivo anatomical 3D MR images were acquired as a guide to perform B0 shimming on a voxel (orange) and to position the DMI grid (green). Figures have been adapted from: https://doi.org/10.3389/fphys.2023.1198578. Used under a Creative Commons CC-BY 4.0 license.

This is an example of research that can be supported by the Euro-BioImaging’s PRIME Node.

About Euro-BioImaging’s PRIME Node

The Dutch Preclinical Imaging Center PRIME – Molecular Imaging Node is a dual-sited Node that consists of the Preclinical Imaging Centre (PRIME), Radboud University Nijmegen, and the Intravital Microscopy Facility (IMF), Hubrecht Institute, Utrecht. This Node is a centralized facility for multimodality imaging of small animals, such as mice and rats. PRIME is the only centre in the Netherlands where more than four imaging modalities for small animal imaging are housed under one roof in one facility. The intravital microscopy laboratory offers advanced genetic mouse models and has heavily invested in state-of-the-art imaging of small animals using multiphoton microscopy. PRIME functions as single-site facility for small animal imaging with state-of-the-art equipment and expertise for magnetic resonance imaging (MRI), positron emission tomography (PET/CT), single photon emission computed tomography (SPECT/CT), intravital multi-photon fluorescence imaging (MPFI) and high frequency ultrasound imaging (HFUS).


More news from Euro-BioImaging

June 30, 2025

VISITING THE PRIME NODE

With the occasion of the Board meeting which took place in Amsterdam last May, the Med-Hub section Director Linda Chaabane and the Med-Hub Head…

CANDLE logo

June 24, 2025

EU Project CANDLE starts building National Cancer Data Nodes

The EU-funded project CANDLE – National CAncer data Node DeveLopErs – officially kicked off on 1st of June 2025, launching its three-year mission to…

June 20, 2025

AgroSERV's 4th call for access is open

AgroServ is a transdisciplinary initiative supported by the European Union through the Horizon Europe program and will continue until 2027. It supports the research…